Preconditioning in lowered oxygen enhances the therapeutic potential of human umbilical mesenchymal stem cells in a rat model of spinal cord injury
Autor: | Shi Benchao, Yao Shun, Dong Chao, Mo Biling, Huang Shuai, Zhang Hui, Zhou Zhilai, Qiu Sujun |
---|---|
Rok vydání: | 2016 |
Předmět: |
0301 basic medicine
Cell Survival Apoptosis Mesenchymal Stem Cell Transplantation Andrology Random Allocation 03 medical and health sciences Paracrine signalling chemistry.chemical_compound 0302 clinical medicine Neurotrophic factors medicine Animals Humans Molecular Biology Spinal cord injury Cells Cultured Spinal Cord Injuries Cell Proliferation business.industry Macrophages General Neuroscience Mesenchymal stem cell Mesenchymal Stem Cells Recovery of Function medicine.disease Cell Hypoxia Nerve Regeneration Rats Transplantation Vascular endothelial growth factor Disease Models Animal 030104 developmental biology chemistry Immunology Hepatocyte growth factor Cord Blood Stem Cell Transplantation Microglia Neurology (clinical) Stem cell business 030217 neurology & neurosurgery Developmental Biology medicine.drug |
Zdroj: | Brain Research. 1642:426-435 |
ISSN: | 0006-8993 |
DOI: | 10.1016/j.brainres.2016.04.025 |
Popis: | Human umbilical cord mesenchymal stem cells (UCMSCs) have recently been shown to hold great therapeutic potential for the treatment of spinal cord injury (SCI). However, the number of engrafted cells has been shown to decrease dramatically post-transplantation. Physioxia is known to enhance the paracrine properties and immune modulation of stem cells, a notion that has been applied in many clinical settings. We therefore hypothesized that preconditioning of UCMSCs in physioxic environment would enhance the regenerative properties of these cells in the treatment of rat SCI. UCMSCs were pretreated with either atmospheric normoxia (21% O2, N-UCMSC) or physioxia (5% O2, P-UCMSC). The MSCs were characterized using flow cytometry, immunocytochemistry, and real-time polymerase chain reaction. Furthermore, 10(5) N-UCMSC or P-UCMSC were injected into the injured spinal cord immediately after SCI, and locomotor function as well as cellular, molecular and pathological changes were compared between the groups. We found that N-UCMSC and P-UCMSC displayed similar surface protein expression. P-UCMSC grew faster, while physioxia up-regulated the expression of trophic and growth factors, including hepatocyte growth factor (HGF), brain-derived neurotrophic factor (BDNF) and vascular endothelial growth factor(VEGF), in UCMSCs. Compared to N-UCMSC, treatment with P-UCMSC was associated with marked changes in the SCI environment, with a significant increase in axonal preservation and a decrease in the number of caspase-3+ cells and ED-1+ macrophages. These changes were accompanied by improved functional recovery. Thus, the present study indicated that preculturing UCMSCs under 5% lowered oxygen physioxic conditions prior to transplantation improves their therapeutic potential for the treatment of SCI in rats. |
Databáze: | OpenAIRE |
Externí odkaz: |